Global 1,3 Dimethyl-2-Imidazolidinone 麻豆原创 Growth 2025-2031

Publication ID:

LPI01251617

Publication Date:

January 20, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global 1,3 Dimethyl-2-Imidazolidinone market size is predicted to grow from US$ 25.7 million in 2025 to US$ 34.5 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.
1,3 Dimethyl-2-Imidazolidinone is a high purity aprotic solvent, is composed of nitrogen containing five membered ring compound and widely recognized as an epoch making solvent. It is a colorless, transparent, high polar solvent with high thermal and chemical stability and non-corrosiveness.
1,3-Dimethyl-2-imidazolidinone (DMI) is compatible with a variety of reagents used in chemical synthesis, allowing it to function effectively in diverse reaction conditions. It does not react with most reagents used in organic and inorganic chemistry, making it a stable medium. With increasing environmental concerns and regulatory restrictions on hazardous solvents, there is a rising demand for sustainable alternatives. DMI emerges as an attractive option due to its low toxicity, high boiling point, and negligible contribution to ozone depletion. As industries strive to adopt eco-friendly practices, the demand for DMI as a green solvent is expected to rise, further propelling its market growth.
The 鈥�1,3 Dimethyl-2-Imidazolidinone Industry Forecast鈥� looks at past sales and reviews total world 1,3 Dimethyl-2-Imidazolidinone sales in 2024, providing a comprehensive analysis by region and market sector of projected 1,3 Dimethyl-2-Imidazolidinone sales for 2025 through 2031. With 1,3 Dimethyl-2-Imidazolidinone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1,3 Dimethyl-2-Imidazolidinone industry.
This Insight Report provides a comprehensive analysis of the global 1,3 Dimethyl-2-Imidazolidinone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1,3 Dimethyl-2-Imidazolidinone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global 1,3 Dimethyl-2-Imidazolidinone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1,3 Dimethyl-2-Imidazolidinone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1,3 Dimethyl-2-Imidazolidinone.
This report presents a comprehensive overview, market shares, and growth opportunities of 1,3 Dimethyl-2-Imidazolidinone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
鈮�99%
<99%
Segmentation by Application:
Industrial Solvent
Pharmaceutical
Electronic Solvent
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mitsui Chemicals
Hebei Kangzhuang Environmental Protection Technology
Sankyo Chemical
Actylis (New Mountain Capital)
Huateng Pharma
Beijing Wisdom Chemical
Haihang Industry
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1,3 Dimethyl-2-Imidazolidinone market?
What factors are driving 1,3 Dimethyl-2-Imidazolidinone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1,3 Dimethyl-2-Imidazolidinone market opportunities vary by end market size?
How does 1,3 Dimethyl-2-Imidazolidinone break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global 1,3 Dimethyl-2-Imidazolidinone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for 1,3 Dimethyl-2-Imidazolidinone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for 1,3 Dimethyl-2-Imidazolidinone by Country/Region, 2020, 2024 & 2031
2.2 1,3 Dimethyl-2-Imidazolidinone Segment by Type
2.2.1 鈮�99%
2.2.2 <99%
2.3 1,3 Dimethyl-2-Imidazolidinone Sales by Type
2.3.1 Global 1,3 Dimethyl-2-Imidazolidinone Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global 1,3 Dimethyl-2-Imidazolidinone Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global 1,3 Dimethyl-2-Imidazolidinone Sale Price by Type (2020-2025)
2.4 1,3 Dimethyl-2-Imidazolidinone Segment by Application
2.4.1 Industrial Solvent
2.4.2 Pharmaceutical
2.4.3 Electronic Solvent
2.4.4 Others
2.5 1,3 Dimethyl-2-Imidazolidinone Sales by Application
2.5.1 Global 1,3 Dimethyl-2-Imidazolidinone Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global 1,3 Dimethyl-2-Imidazolidinone Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global 1,3 Dimethyl-2-Imidazolidinone Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global 1,3 Dimethyl-2-Imidazolidinone Breakdown Data by Company
3.1.1 Global 1,3 Dimethyl-2-Imidazolidinone Annual Sales by Company (2020-2025)
3.1.2 Global 1,3 Dimethyl-2-Imidazolidinone Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global 1,3 Dimethyl-2-Imidazolidinone Annual Revenue by Company (2020-2025)
3.2.1 Global 1,3 Dimethyl-2-Imidazolidinone Revenue by Company (2020-2025)
3.2.2 Global 1,3 Dimethyl-2-Imidazolidinone Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global 1,3 Dimethyl-2-Imidazolidinone Sale Price by Company
3.4 Key Manufacturers 1,3 Dimethyl-2-Imidazolidinone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 1,3 Dimethyl-2-Imidazolidinone Product Location Distribution
3.4.2 Players 1,3 Dimethyl-2-Imidazolidinone Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for 1,3 Dimethyl-2-Imidazolidinone by Geographic Region
4.1 World Historic 1,3 Dimethyl-2-Imidazolidinone 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global 1,3 Dimethyl-2-Imidazolidinone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global 1,3 Dimethyl-2-Imidazolidinone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic 1,3 Dimethyl-2-Imidazolidinone 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global 1,3 Dimethyl-2-Imidazolidinone Annual Sales by Country/Region (2020-2025)
4.2.2 Global 1,3 Dimethyl-2-Imidazolidinone Annual Revenue by Country/Region (2020-2025)
4.3 Americas 1,3 Dimethyl-2-Imidazolidinone Sales Growth
4.4 APAC 1,3 Dimethyl-2-Imidazolidinone Sales Growth
4.5 Europe 1,3 Dimethyl-2-Imidazolidinone Sales Growth
4.6 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone Sales Growth
5 Americas
5.1 Americas 1,3 Dimethyl-2-Imidazolidinone Sales by Country
5.1.1 Americas 1,3 Dimethyl-2-Imidazolidinone Sales by Country (2020-2025)
5.1.2 Americas 1,3 Dimethyl-2-Imidazolidinone Revenue by Country (2020-2025)
5.2 Americas 1,3 Dimethyl-2-Imidazolidinone Sales by Type (2020-2025)
5.3 Americas 1,3 Dimethyl-2-Imidazolidinone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 1,3 Dimethyl-2-Imidazolidinone Sales by Region
6.1.1 APAC 1,3 Dimethyl-2-Imidazolidinone Sales by Region (2020-2025)
6.1.2 APAC 1,3 Dimethyl-2-Imidazolidinone Revenue by Region (2020-2025)
6.2 APAC 1,3 Dimethyl-2-Imidazolidinone Sales by Type (2020-2025)
6.3 APAC 1,3 Dimethyl-2-Imidazolidinone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 1,3 Dimethyl-2-Imidazolidinone by Country
7.1.1 Europe 1,3 Dimethyl-2-Imidazolidinone Sales by Country (2020-2025)
7.1.2 Europe 1,3 Dimethyl-2-Imidazolidinone Revenue by Country (2020-2025)
7.2 Europe 1,3 Dimethyl-2-Imidazolidinone Sales by Type (2020-2025)
7.3 Europe 1,3 Dimethyl-2-Imidazolidinone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone by Country
8.1.1 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone Sales by Country (2020-2025)
8.1.2 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone Revenue by Country (2020-2025)
8.2 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone Sales by Type (2020-2025)
8.3 Middle East & Africa 1,3 Dimethyl-2-Imidazolidinone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 1,3 Dimethyl-2-Imidazolidinone
10.3 Manufacturing Process Analysis of 1,3 Dimethyl-2-Imidazolidinone
10.4 Industry Chain Structure of 1,3 Dimethyl-2-Imidazolidinone
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 1,3 Dimethyl-2-Imidazolidinone Distributors
11.3 1,3 Dimethyl-2-Imidazolidinone Customer
12 World Forecast Review for 1,3 Dimethyl-2-Imidazolidinone by Geographic Region
12.1 Global 1,3 Dimethyl-2-Imidazolidinone 麻豆原创 Size Forecast by Region
12.1.1 Global 1,3 Dimethyl-2-Imidazolidinone Forecast by Region (2026-2031)
12.1.2 Global 1,3 Dimethyl-2-Imidazolidinone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global 1,3 Dimethyl-2-Imidazolidinone Forecast by Type (2026-2031)
12.7 Global 1,3 Dimethyl-2-Imidazolidinone Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Mitsui Chemicals
13.1.1 Mitsui Chemicals Company Information
13.1.2 Mitsui Chemicals 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.1.3 Mitsui Chemicals 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Mitsui Chemicals Main Business Overview
13.1.5 Mitsui Chemicals Latest Developments
13.2 Hebei Kangzhuang Environmental Protection Technology
13.2.1 Hebei Kangzhuang Environmental Protection Technology Company Information
13.2.2 Hebei Kangzhuang Environmental Protection Technology 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.2.3 Hebei Kangzhuang Environmental Protection Technology 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hebei Kangzhuang Environmental Protection Technology Main Business Overview
13.2.5 Hebei Kangzhuang Environmental Protection Technology Latest Developments
13.3 Sankyo Chemical
13.3.1 Sankyo Chemical Company Information
13.3.2 Sankyo Chemical 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.3.3 Sankyo Chemical 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sankyo Chemical Main Business Overview
13.3.5 Sankyo Chemical Latest Developments
13.4 Actylis (New Mountain Capital)
13.4.1 Actylis (New Mountain Capital) Company Information
13.4.2 Actylis (New Mountain Capital) 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.4.3 Actylis (New Mountain Capital) 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Actylis (New Mountain Capital) Main Business Overview
13.4.5 Actylis (New Mountain Capital) Latest Developments
13.5 Huateng Pharma
13.5.1 Huateng Pharma Company Information
13.5.2 Huateng Pharma 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.5.3 Huateng Pharma 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Huateng Pharma Main Business Overview
13.5.5 Huateng Pharma Latest Developments
13.6 Beijing Wisdom Chemical
13.6.1 Beijing Wisdom Chemical Company Information
13.6.2 Beijing Wisdom Chemical 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.6.3 Beijing Wisdom Chemical 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Beijing Wisdom Chemical Main Business Overview
13.6.5 Beijing Wisdom Chemical Latest Developments
13.7 Haihang Industry
13.7.1 Haihang Industry Company Information
13.7.2 Haihang Industry 1,3 Dimethyl-2-Imidazolidinone Product Portfolios and Specifications
13.7.3 Haihang Industry 1,3 Dimethyl-2-Imidazolidinone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Haihang Industry Main Business Overview
13.7.5 Haihang Industry Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.